...
首页> 外文期刊>Heart >Incidence, clinical characteristics and outcome of congestive heart failure as the initial presentation in patients with primary hyperthyroidism
【24h】

Incidence, clinical characteristics and outcome of congestive heart failure as the initial presentation in patients with primary hyperthyroidism

机译:原发性甲亢患者最初表现为充血性心力衰竭的发生率,临床特征和结局

获取原文
获取原文并翻译 | 示例
           

摘要

Background: There are limited systematic data on the incidence, clinical characteristics and outcomes of congestive heart failure (CHF) in patients with hyperthyroidism. The aim of this study was to investigate the incidence, clinical characteristics and outcome of CHF as the initial presentation in patients with primary hyperthyroidism.rnMethods: The prevalence, clinical characteristics and outcome of CHF was studied in 591 consecutive patients (mean (SD) age 45 (1) years, 140 men) who presented with primary hyperthyroidism. Results: CHF was the presenting condition in 34 patients (5.8%) with hyperthyroidism. The presence of atrial fibrillation at presentation (OR 37.4, 95% CI 9.72 to 144.0, p < 0.001) was an independent predictor for the occurrence of CHF. Of the 34 patients with CHF, 16 (47%) had systolic left ventricular dysfunction with left ventricular ejection fraction (LVEF) < 50%. They were predominantly male (OR 26.6, 95% CI 2.6 to 272.5, p = 0.006) and had a lower serum thyroxine level (OR 0.93, 95% CI 0.87 to 0.99, p = 0.044) than patients with preserved left ventricular systolic function. In these patients, LVEF (55 (4)% vs 30 (2)%, p < 0.001) and New York Heart Association functional class (1.2 (0.1) vs 2.5 (0.2), p < 0.001) improved significantly 3 months after achieving euthyroid status. Systolic left ventricular dysfunction (mean (SD) LVEF 38 (4)%) persisted on long-term follow-up in five patients: no clinical parameter could be identified to predict the occurrence of this persistent cardiomyopathy (p > 0.05).rnConclusion: CHF was the initial clinical presentation in approximately 6% of patients with hyperthyroidism, and half of them had left ventricular systolic dysfunction. Symptoms of CHF subsided and LVEF improved after treatment for hyperthyroidism. Nonetheless, one-third of these patients developed persistent dilated cardiomyopathy.
机译:背景:关于甲状腺功能亢进症患者充血性心力衰竭(CHF)的发生率,临床特征和结局的系统性数据有限。本研究旨在探讨原发性甲状腺功能亢进症患者CHF的发病率,临床特征和预后。方法:对591名连续(平均)年龄的CHF的患病率,临床特征和预后进行研究。 45(1)岁,140名男性)表现为原发性甲亢。结果:CHF是甲状腺功能亢进症34例(5.8%)的表现。出现房颤时(OR 37.4,95%CI 9.72至144.0,p <0.001)是CHF发生的独立预测因子。在34例CHF患者中,有16例(47%)患有收缩期左心室功能不全,左心室射血分数(LVEF)<50%。他们主要是男性(OR 26.6,95%CI 2.6至272.5,p = 0.006),并且血清甲状腺素水平较低(OR 0.93,95%CI 0.87至0.99,p = 0.044),而这些患者的左心室收缩功能得以保留。在这些患者中,LVEF(55(4)%vs 30(2)%,p <0.001)和纽约心脏协会功能等级(1.2(0.1)vs 2.5(0.2),p <0.001)显着改善,达到3个月甲状腺功能正常。长期随访的5例患者持续存在收缩期左心室功能不全(平均值(SD)LVEF 38(4)%):尚无临床参数可预测这种持续性心肌病的发生(p> 0.05)。结论: CHF是大约6%的甲亢患者的最初临床表现,其中一半患有左心室收缩功能障碍。甲亢治疗后,CHF症状减轻,LVEF改善。然而,这些患者中有三分之一发展为持续性扩张型心肌病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号